RT Book, Section
A1 Flieder, Douglas B.
A2 Grippi, Michael A.
A2 Elias, Jack A.
A2 Fishman, Jay A.
A2 Kotloff, Robert M.
A2 Pack, Allan I.
A2 Senior, Robert M.
A2 Siegel, Mark D.
SR Print(0)
ID 1122368153
T1 Lymphoproliferative and Hematologic Diseases Involving the Lung and Pleura
T2 Fishman's Pulmonary Diseases and Disorders, 5e
YR 2015
FD 2015
PB McGraw-Hill Education
PP New York, NY
SN 978-0-07-179672-9
LK accessmedicine.mhmedical.com/content.aspx?aid=1122368153
RD 2023/03/30
AB Lymphoproliferative  disorders  of  the  lung  and  pleura  comprise  a  varied  but  rare  group  of  localized  and  diffuse  processes  that  span  the  morphologic  gamut  from  reactive  to  neoplastic  and  include  several  peculiar  lesions  that  do  not  fit  conventional  definitions  of  either  hyperplasia  or  neoplasia.  Although  most  diagnoses  are  based  on  light  microscopy,  immunohistochemical  and  molecular  investigations  have  assumed  a  vital  role.  Nomenclature  and  classification  schemes  have  undergone  drastic  changes  over  the  past  quarter  century  and  current  definitions  appear  reasonable.  Malignant  lesions  are  best  classified  according  to  the  current  World  Health  Organization  (WHO)  scheme.1  This  chapter  presents  the  clinicopathologic  features  of  primary  and  secondary  pulmonary  and  pleural  hematolymphoid  lesions.